Clinical Research
Call
We currently have clinical studies for people with Parkinson’s disease, atypical parkinsonisms, orthostatic hypotension, and healthy volunteers:
Trials Currently Recruiting
- Axial Biotherapeutics Inc: The effect of AB-4166 on GI tolerability and gut microbiome in a free-living subset of Parkinson’s patients
- Denali Biomarker Study: A prospective collection of whole blood from patients with Parkinson’s disease and matched healthy volunteers at Parkinson’s Institute and Clinical Center for research purposes
- National Parkinson Foundation: Parkinson’s Foundation Quality Improvement Initiative
- Lundbeck RESTORE: A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of droxidopa therapy
Active Trials, Not Currently Recruiting
- Sanofi MOVES-PD: Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients With Early-stage Parkinson’s Disease Carrying a GBA Mutation or Other Pre-specified Variant
- ESB Biomarker: Biomarker Discovery in Parkinson’s Disease
- Gastrointestinal Natural History Study: A Two-Year Prospective Longitudinal Study using Quantitative and Qualitative Assessments to Define the Natural History of Gastrointestinal Symptoms in Patients with Parkinson’s Disease or at Risk for Developing the Motor Symptoms of Parkinson’s Disease
- Cala Health: PROSPECT: Prospective study for Symptomatic Relief of Essential Tremor with Cala Therapy
- Retrotope: Individual Patient Expanded Access Protocol for the Treatment of a Single Patient with Progressive Supranuclear Palsy with RT001